Weather Advisory: Temporary Door Closure

Due to extreme cold, access through the Moakley Building's entrance off Boston Medical Center Place will be temporarily closed from 5 p.m. Friday, Jan. 30, through 7 a.m. Monday, Feb. 2.

All patients and visitors should use the main entrance for the Menino and Yawkey Buildings during this time. The hospital remains open and operating as normal.

We appreciate your patience as we take these precautions during severe winter weather.

About

Umit Tapan, MD, is a thoracic oncologist at Boston Medical Center (BMC) and an assistant professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. Dr. Tapan specializes in non-small cell lung cancer, small cell lung cancer, mesothelioma, immunotherapy, targeted therapy/precision medicine. His research interests center on reducing disparities in lung cancer treatment, improving access to new treatments such as immunotherapy and targeted treatment. After receiving his medical degree from Hacettepe University School of Medicine in Turkey, Dr. Tapan completed his internship and residency at Steward Carney Hospital and a fellowship in hematology and oncology at Boston University Medical Center.
  • Specialties

    Non-small cell lung cancer, small-cell lung cancer, mesothelioma, immunotherapy, targeted therapy

  • Languages

    Turkish
  • Contact

    617.638.6428
  • Primary Location

    830 Harrison
    3rd Floor
    Boston, MA 02118
  • Administrative Title

    Assistant Professor of Medicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, BU-BMC Cancer Center. Member, Evans Center for Interdisciplinary Biomedical Research, Boston University.

  • Residency

    Internal Medicine, Steward Carney Hospital, 2010-2012
  • Fellowship

    Hematology and Medical Oncology, Boston University Medical Center, 2014-2015
  • Education

    Hacettepe University Faculty of Medicine, Turkey, 2006
  • Board Certifications

    Internal Medicine, Hematology, Medical Oncology, American Board of Internal Medicine
  • Research Interests

    Disparities in lung cancer care, predictors of immunotherapy response/toxicity

Affiliations

Affiliations